Literature DB >> 25617999

Are we waking up to the effects of NEFA?

Jonathan C Jun1, Vsevolod Y Polotsky.   

Abstract

NEFA are mobilised from adipose tissues during fasting or stress. Under conditions of acute or chronic NEFA excess, skeletal muscle and hepatic insulin resistance may ensue. Hence, a wealth of literature has focused on the crosstalk between NEFA and glucose in the pathogenesis of insulin resistance. Sleep restriction has also been shown to acutely induce insulin resistance, and self-reported short sleep duration is associated with diabetes. In this issue of Diabetologia (DOI: 10.1007/s00125-015-3500-4), Broussard and colleagues examine the impact of acute sleep restriction on detailed 24 h metabolic profiles, including plasma NEFA. Here, we address the potential clinical relevance of these findings and pose questions for further research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25617999      PMCID: PMC4352391          DOI: 10.1007/s00125-014-3489-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

Review 1.  Sleep disorders and the development of insulin resistance and obesity.

Authors:  Omar Mesarwi; Jan Polak; Jonathan Jun; Vsevolod Y Polotsky
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

2.  Impact of sleep debt on metabolic and endocrine function.

Authors:  K Spiegel; R Leproult; E Van Cauter
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

Review 3.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

Authors:  P J Randle
Journal:  Diabetes Metab Rev       Date:  1998-12

Review 4.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Authors:  Hanrui Zhang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-12-22       Impact factor: 17.165

Review 5.  Free fatty acids (FFA), a link between obesity and insulin resistance.

Authors:  G Boden
Journal:  Front Biosci       Date:  1998-02-15

6.  Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.

Authors:  A T Santomauro; G Boden; M E Silva; D M Rocha; R F Santos; M J Ursich; P G Strassmann; B L Wajchenberg
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

Review 7.  Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes.

Authors:  Karine Spiegel; Kristen Knutson; Rachel Leproult; Esra Tasali; Eve Van Cauter
Journal:  J Appl Physiol (1985)       Date:  2005-11

8.  Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes.

Authors:  Sangeeta R Kashyap; Renata Belfort; Rachele Berria; Swangjit Suraamornkul; Thongchai Pratipranawatr; Jean Finlayson; Andrea Barrentine; Mandeep Bajaj; Lawrence Mandarino; Ralph DeFronzo; Kenneth Cusi
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-04       Impact factor: 4.310

9.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.

Authors:  A Dresner; D Laurent; M Marcucci; M E Griffin; S Dufour; G W Cline; L A Slezak; D K Andersen; R S Hundal; D L Rothman; K F Petersen; G I Shulman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index.

Authors:  Shahrad Taheri; Ling Lin; Diane Austin; Terry Young; Emmanuel Mignot
Journal:  PLoS Med       Date:  2004-12-07       Impact factor: 11.069

View more
  1 in total

1.  The Effect of Hypoxia and Metformin on Fatty Acid Uptake, Storage, and Oxidation in L6 Differentiated Myotubes.

Authors:  Martina Musutova; Moustafa Elkalaf; Natalie Klubickova; Michal Koc; Stanislav Povysil; Jan Rambousek; Beatriz Volckaert; Frantisek Duska; Minh Duc Trinh; Martin Kalous; Jan Trnka; Kamila Balusikova; Jan Kovar; Jan Polak
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-17       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.